
Oppenheimer keeps 'Outperform' on Palantir with $200 target, seeing 63% upside ahead of Q2 earnings.
Oppenheimer reaffirmed its 'Outperform' rating on Palantir, setting a $200 price target that implies a 63% gain from current levels. The firm expects Palantir to beat Q2 revenue estimates and raise its full-year outlook, driven by strong demand from ...


